Ireland’s pharmaceutical market will remain on an improved growth trajectory over the next five years relative to theprevious five years. A growing and ageing population, combined with rising health expenditure and the multi-year health sectorreform, will support this trend. However, the market attractiveness to innovative drugmakers will remain subdued due to the slowuptake of new medicines and persistent cost-control measures targeting drug spending. Meanwhile, Ireland’s export-ledpharmaceutical manufacturing industry will continue to drive interest from investors given tax incentives and rising global demandfor pharmaceutical products.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook